Bio-Rad Laboratories, Inc. (BIO)
279.03
-5.65
(-1.98%)
USD |
NYSE |
Mar 05, 16:00
279.11
+0.08
(+0.03%)
Pre-Market: 20:00
Bio-Rad Laboratories Cash from Investing (Quarterly) : -34.20M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -93.00M |
| Bruker Corp. | -55.50M |
| Azenta, Inc. | 36.77M |
| Harvard Bioscience, Inc. | -0.348M |
| Bionano Genomics, Inc. | -4.669M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 164.90M |
| Cash from Financing (Quarterly) | 3.30M |
| Free Cash Flow | 374.60M |
| Free Cash Flow Per Share (Quarterly) | 4.409 |
| Free Cash Flow to Equity (Quarterly) | 129.10M |
| Free Cash Flow to Firm (Quarterly) | 128.48M |
| Free Cash Flow Yield | 4.92% |